Alberto Bardelli is Full Professor at the Department of Oncology, University of Torino and Director of the Laboratory of Molecular Oncology at Candiolo Cancer Institute FPO-IRCCS, Italy.
Prof Bardelli studied biological sciences at the University of Turin, graduating cum laude with an honourable mention. After graduation he moved to the Ludwig Institute for Cancer Research in London where he obtained a PhD in Biochemistry and Molecular Biology. He is a molecular geneticist and expert in the field of personalized therapies, with work aimed at developing precision medicines for cancer patients.
Discoveries from his group have led to the development of diagnostic tests based on the genetic profiles of individual tumours that represent the first example of personalised therapies for colorectal cancer patients.
In 2014 Prof Bardelli was listed in the Thomson Reuters List of Highly Cited Researchers and he is the author of over 200 peer-reviewed manuscripts. In 2016 he won the Grant for Oncology Innovation Research Project and in 2017 was recognised with the ESMO Translational Research Award. He is President of the European Association for Cancer Research.
Press return to search